385: Autoimmunity, Lyme Disease, and Essential Oils with Dr. Jaquel Patterson, ND, MBA, IFMCP
The Essential Oil Revolution - Health, Purpose, and Aromatherapy
Dr. Sarah LoBisco
4.4 • 663 Ratings
🗓️ 24 October 2023
⏱️ 64 minutes
🧾️ Download transcript
Summary
What You Will Learn:
Biography of Dr. Jaquel Patterson
Dr. Jaquel Patterson is a nationally recognized naturopathic physician, success coach, 3x Amazon best-selling author (Long Covid & Beyond, Women and Lyme, and Naturalpreneurs), and Forbes contributor. She has over 15 years of clinical experience with a focus on Lyme disease, autoimmune conditions, integrative psychiatry, and environmental medicine and she owns a successful multidisciplinary medical practice, Fairfield Family Health, in Connecticut.
Dr. Patterson is also a certified practitioner through the Institute Functional Medicine (IFM) and completed a fellowship in functional medicine for psychiatry and ADD/ADHD.
She served as the past president of the American Association of Naturopathic Physicians, and currently serves on the board of the American Academy of Environmental Medicine. Dr. Patterson also sat on many other medical professional boards throughout her career and is a current member of various associations in her specialties like ILADS.
Dr. Patterson further uses her gifts for coaching other integrative practitioners to build successful, and scalable integrative medical practices so they can thrive in both business and life. Her entrepreneurial and business mind, which was nurtured through her MBA in Healthcare Management from Quinnipiac University and undergraduate degree in Applied Economics and Management from Cornell, manifested in her own online supplement and health community, Naturalmins.
Learn more about your ad choices. Visit megaphone.fm/adchoices
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Barclay's ready-made investments. The clue's in the name. |
| 0:04.0 | Not Barclays, where do I begin investments? |
| 0:06.0 | You can start from £50. |
| 0:08.0 | That's why they're not difficult to get started investments either. |
| 0:12.0 | And you can choose your risk level, so they're hardly in at the deep end investments. |
| 0:16.0 | So, if you've got savings and you want to help grow your money over five years or more, |
| 0:20.0 | then search Barclays ready-made investments. |
| 0:22.7 | Make money work for you. |
| 0:24.2 | Investing is not for everyone. |
| 0:25.5 | The value of investments can fall as well as rise and you may get back less than you invest. |
| 0:29.0 | Teas and Cs apply. |
| 0:31.5 | Empowerment in education. |
| 0:33.3 | Two powerful elements that will help you break free of convention and transform your passion for wellness to a level beyond the status quo. |
| 0:40.8 | The Essential Oil Revolution, |
| 0:43.0 | where you're given the tools to supersede an ordinary everyday lifestyle, |
| 0:47.0 | inspiring speakers, DIY recipes, healthy living tips, and more. |
| 0:51.9 | You'll discover it all here. |
| 0:53.9 | So tune in and get ready for a wellness |
| 0:57.1 | revolution. Welcome to the Essential Oil's Revolution. I'm your host, Dr. Sarah Lobisco, and I am so |
| 1:05.6 | excited to be with you today for another episode. It is my honor to share educational information and to bring to you |
| 1:13.5 | leading experts and clinicians to empower you in your use of essential oils and to inspire you |
| 1:20.6 | as you move beyond the status quo and into optimized wellness through integrative health, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Dr. Sarah LoBisco, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dr. Sarah LoBisco and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

